A predicted interaction between odour pleasantness and intensity provides evidence for major histocompatibility complex social signalling in women.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

1. Olfactory and Gustatory Outcomes Including Health-Related Quality of Life 3-6 and 12 Months after Severe-to-Critical COVID-19: A SECURe Prospective Cohort Study.Journal of clinical medicine · 2022
   Article
2. Accumulating evidence suggests that men do not find body odours of human leucocyte antigen-dissimilar women more attractive.Proceedings. Biological sciences · 2018
   Article

Corrections and comments

• Commented on by
  Accumulating evidence suggests that men do not find body odours of human leucocyte antigen-dissimilar women more attractive.2018
• Comment on
  Men's preferences for women's body odours are not associated with human leucocyte antigen.2017

Authors and funding

1 author at 1 institution in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as